Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SNX11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MTMR11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PAQR7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100996740 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SLC1A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
JADE2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LDOC1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KLF3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C19orf12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANKRD35 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MLLT3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NFATC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAST4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMPD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WNT5A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLAUR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WARS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TNFSF15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on